Core Insights - Cocrystal Pharma, Inc. will participate in a fireside chat at the Noble Capital Markets' 2025 Emerging Growth Virtual Equity Conference on June 5, 2025 [1] - The company is a clinical-stage biotechnology firm focused on developing antiviral therapeutics targeting various viruses [3] Company Overview - Cocrystal Pharma specializes in discovering and developing novel antiviral drugs aimed at noroviruses, influenza viruses, coronaviruses (including SARS-CoV-2), and hepatitis C viruses [3] - The company utilizes unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral therapeutics [3] Event Details - Registered investors can request one-on-one meetings with Cocrystal management through the conference registration platform [2] - A video webcast of the presentation will be available approximately 48 hours after the event and archived for 90 days on the company's website and Channelchek [2]

Group 1: Company Overview - Cocrystal Pharma, Inc. is a clinical-stage biotechnology company focused on discovering and developing novel antiviral therapeutics targeting the replication processes of various viruses, including influenza, coronaviruses (such as SARS-CoV-2), noroviruses, and hepatitis C viruses [3] - The company utilizes unique structure-based technologies and Nobel Prize-winning expertise to create first- and best-in-class antiviral drugs [3] Group 2: Event Information - Sam Lee, President and co-CEO of Cocrystal Pharma, will present a company overview at the Life Science Innovation Northwest (LSINW) 2025 Conference on April 23, 2025, at 3:00 p.m. Pacific time [1] - The LSINW conference is the largest annual life science event in the Pacific Northwest, featuring over 700 attendees and 80+ presentations from companies and research institutions [2] - The conference includes keynote addresses from industry leaders, panel discussions on emerging trends, and a startup fast pitch showdown, making it a significant event for the life science community in the region [2]